204981-48-6

204981-48-6 structure

Name: CP-195543
Chemical Name: (3S,4R)-7-(2-carboxy-5-trifluoromethylphenyl)-4-hydroxy-3-benzyl-3,4-dihydro-2H-1-benzopyran
CAS Number: 204981-48-6
Molecular Formula: C₂₄H₁₉F₃O₄
Molecular Weight: 428.40000
Catalog: Signaling Pathways GPCR/G Protein Leukotriene Receptor
Create Date: 2016-09-12 16:53:05
Modify Date: 2024-01-12 16:24:17
CP-195543 is a potent, selective and orally active leukotriene B4 (LTB4) receptor antagonist with IC50s of 6.8, 37.0 nM for human neutrophils and murine spleen membranes, respectively. CP-195543 blocks CD11b up-regulation. CP-195543 inhibits LTB4-mediated neutrophil infiltration[1].

Name	(3S,4R)-7-(2-carboxy-5-trifluoromethylphenyl)-4-hydroxy-3-benzyl-3,4-dihydro-2H-1-benzopyran
Synonyms	2-[(3S,4R)-3,4-dihydro-4-hydroxy-3-(phenylmethyl)-2H-1-benzopyran-7-yl]-4-(trifluoromethyl)benzoic acid (3S-trans)-2-[3,4-dihydro-4-hydroxy-3-(phenylmethyl)-2H-1-benzopyran-7-yl]-4-(trifluoromethyl)-benzoic acid

Description	CP-195543 is a potent, selective and orally active leukotriene B4 (LTB4) receptor antagonist with IC50s of 6.8, 37.0 nM for human neutrophils and murine spleen membranes, respectively. CP-195543 blocks CD11b up-regulation. CP-195543 inhibits LTB4-mediated neutrophil infiltration[1].
Related Catalog	Signaling Pathways >> GPCR/G Protein >> Leukotriene Receptor Research Areas >> Inflammation/Immunology
Target	LTB4
In Vitro	CP-195543 抑制由 LTB4 介导的人和小鼠中性粒细胞趋化性，IC50 值分别为 2.4 nM、7.5 nM[1]。 CP-195543 (0.1 nM-10 µM；60 分钟) 阻断人中性粒细胞 (HN) 和小鼠中性粒细胞中 CD11b 的上调，对人单核细胞和嗜酸性粒细胞的 IC50 值分别为 270、420 nM [1]。
In Vivo	CP-195543 (0.01, 0.1, 1, 10 mg/kg for guinea pig; 0.01, 0.1, 1, 10, 100 mg/kg for mice; P.o.; 1 h before injection of LTB4) 呈剂量依赖性抑制 LTB4 介导的中性粒细胞浸润[1]。 Animal Model: Guinea pig (Injection of LTB4 10, 30, 100 ng/site; injected intradermally)[1] Dosage: 0.01, 0.1, 1, 10 mg/kg Administration: P.o.; 1 h before injection of LTB4 Result: Inhibited LTB4-mediated neutrophil infiltration in guinea pigskin in a dose-dependent manner. Animal Model: Mice (Injection of LTB4 100 ng/site; injected intradermally)[1] Dosage: 0.01, 0.1, 1, 10, 100 mg/kg Administration: P.o.; 1 h before injection of LTB4 Result: Inhibited LTB4-mediated neutrophil infiltration in guinea pigskin in a dose-dependent manner.
References	[1]. Showell HJ, et al. The preclinical pharmacological profile of the potent and selective leukotriene B4 antagonist CP-195543. J Pharmacol Exp Ther. 1998 Jun;285(3):946-54.

Molecular Formula	C₂₄H₁₉F₃O₄
Molecular Weight	428.40000
Exact Mass	428.12400
PSA	66.76000
LogP	5.35530

204981-48-6	186390-48-7
127966-71-6	83003-12-7
532435-68-0	850467-66-2
257639-98-8	1080622-86-1
220941-93-5	212790-31-3